Advocates Hold Cancer Action Day at State House, Urging Lawmakers to Expand Access to Biomarker Testing & Address Affordability Concerns
Lawmakers asked to reduce barriers to care and reduce prescription related costs
Lawmakers asked to reduce barriers to care and reduce prescription related costs
BISMARCK, N.D. –– North Dakota legislators have strong momentum against cancer heading into the second half of the session as bills on prior authorization reform, supplemental breast cancer detection screenings and co-pay accumulator adjustments are progressing.
BISMARCK, N.D. –– House Bill 1283 cleared the chamber today in a 66-26 vote, putting North Dakotans one step closer to the peace of mind they need when it comes to breast cancer diagnostics. The bill now moves to the Senate for further consideration.
This week, the U.S. House of Representatives is expected to consider a budget resolution that could lead to devastating cuts to Medicaid. Ahead of the vote, the American Cancer Society Cancer Action Network (ACS CAN) is urging House members to oppose cuts to Medicaid.
BISMARCK, N.D. –– For the more than 4,500 North Dakotans who will be diagnosed with cancer in 2025, medical prior authorization can delay treatment, increase stress, and have a negative impact on their care .
Está previsto que el Comité de Presupuesto del Senado presente su resolución presupuestaria esta semana, preparando el terreno para recortes significativos en el gasto discrecional para compensar el costo del paquete.
BISMARCK, N.D. -- The North Dakota House Business, Industry and Labor Committee on Wednesday gave a “do pass recommendation” on legislation that, if successfully passed, will lead to better outcomes in the fight against breast cancer.
PIERRE, S.D. – South Dakota legislators begin a new session today and American Cancer Society Cancer Action Network advocates will urge them to take the opportunity to assure those at risk for breast cancer have the tools needed for early detection and defeat of the disease.
Un nuevo informe (en inglés) de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) descubrió que más del 70% de los pacientes con seguro comercial tuvieron gastos de bolsillo para pruebas de diagnóstico de seguimiento del cáncer de mama en 2023.
BISMARCK, N.D. -- As North Dakota legislators close their first week of business for the new year, American Cancer Society Cancer Action Network advocates on Monday will ask them to take strong action to reduce the cost of fighting cancer.